Earnings Dashboard
INCY
upcomingINCYTE CORPORATION FORMERLY INCYTE GENOMICS INC
Time TBDlarge capTuesday, April 28, 2026
Expected Move Analysis
Expected
9.3%
Current Stock Price
$95.27
Expected Move
±9.3%
±$8.84
IV Rank
41
Moderate
Put/Call Ratio
0.70
Bullish bias
Analysis & Commentary
INCYTE CORPORATION FORMERLY INCYTE GENOMICS INC (INCY) reports earnings Tuesday . Consensus EPS estimate is $1.22.
IV Rank sits at 41, indicating fairly-priced options. Neither premium sellers nor buyers have a clear structural edge here — let your directional thesis guide the trade.
A calendar spread could benefit from the front-month IV crush while maintaining exposure through the back month. Sell the weekly expiration and buy 30-45 DTE.
Enter 2-3 days before earnings. Sell the weekly expiration (front month) and buy 30-45 DTE (back month). The goal is for the front month to decay rapidly with the IV crush while the back month retains value.